Cancer Tissue Diagnostics Market: Driving Factors and Regional Insights
Introduction
The global cancer tissue diagnostics market is on a steady growth trajectory, with a forecasted Compound Annual Growth Rate (CAGR) of 6.9% from 2023 to 2030. The market is expected to expand from a value of US$6.9 billion in 2023 to US$11.1 billion by the end of 2030. This remarkable growth can be attributed to several key factors driving the demand for cancer tissue diagnostics. In this comprehensive report, we will delve into the attributes, market growth drivers, restraints, opportunities, and regional insights shaping the landscape of the cancer tissue diagnostics market.
Attributes of the Global Cancer Tissue Diagnostics Market
Tissue diagnostics have emerged as a reliable and crucial method for cancer diagnosis and treatment planning. They provide valuable insights by capturing the biological context of cancer cells. The global market for cancer tissue diagnostics is witnessing substantial growth, driven by various attributes and key insights:
- Market Size and Growth: In 2023, the market size was estimated at US$6.9 billion, and it is projected to grow to US$11.1 billion by 2030, reflecting a CAGR of 6.9%.
- Historical Growth: From 2018 to 2022, the cancer tissue diagnostics market exhibited a steady historical growth rate of 5.7% CAGR.
- Market Introduction: Tissue diagnostics are becoming increasingly essential in cancer diagnosis and treatment planning, thanks to their ability to capture the biological context of cancer cells. The growing demand for these diagnostics is driven by factors such as rising cancer incidence, preventive healthcare focus, digital pathology applications, cancer awareness initiatives, advancements in diagnostic tools, and improved accuracy.
Market Growth Drivers
Several factors are propelling the growth of the global cancer tissue diagnostics market. These drivers are instrumental in shaping the demand for tissue-based diagnostics:
- Growing Burden of Cancers and Aging Population: Cancer rates are escalating worldwide, with the aging population contributing significantly to the burden. In the UK, cancer incidence is projected to increase from 3.5 million in 2025 to 4 million by 2030. Factors like population growth, aging, increased awareness, and improved diagnostic infrastructure are responsible for this surge.
- Understaffing and Retirement Rates: Histology laboratories, vital for accurate diagnosis, are facing understaffing issues. Only 3% of UK diagnostic labs had sufficient staff in 2020, leading to challenges in processing samples. As histologists retire, there is a shortage of new professionals entering the field, potentially limiting the markets growth.
- Increasing Adoption of Refurbished Diagnostic Imaging Systems: Developing countries often face financial constraints in investing in diagnostic imaging equipment. To overcome this, hospitals in these regions are turning to refurbished imaging systems, which are more cost-effective, making diagnostic services accessible to a broader population. Major companies are actively endorsing refurbished devices through various programs.
- Introduction of Novel Diagnostic Biomarkers: Advances in detection technology and biotechnology have led to the identification of new cancer biomarkers. These biomarkers enhance cancer diagnosis and treatment, creating lucrative opportunities in the cancer diagnostics market.
In a nutshell, the Persistence Market Research report is a must-read for start-ups, industry players, investors, researchers, consultants, business strategists, and all those who are looking to understand this industry. Get a glance at the report at- https://www.persistencemarketresearch.com/market-research/cancer-tissue-diagnostics-market.asp
Regional Insights
The cancer tissue diagnostics market exhibits varying dynamics across different regions:
- North America: North America is witnessing a continuous rise in cancer cases, driving the demand for advanced diagnostic products. The American Cancer Society reported an increase in cancer incidence from 1.91 million in 2021 to 1.96 million in 2023, emphasizing the need for precise diagnostic tools to facilitate early-stage therapies.
- Asia Pacific: The Asia Pacific market is poised for substantial expansion, driven by increasing cancer prevalence, improvements in healthcare services, rising healthcare expenditures, and early cancer screening initiatives. China, in particular, has a high cancer burden, making it a significant focus for the cancer tissue diagnostics industry.
Competitive Intelligence and Business Strategy
Prominent organizations like Abbott Laboratories, F. Hoffmann-La Roche Ltd., and Thermo Fisher Scientific Inc. are at the forefront of the cancer tissue diagnostics market. They leverage their technological expertise and experience in the healthcare industry to provide innovative solutions. Key strategies include advancing diagnostic tests, particularly in the field of personalized medicine, and exploring digital pathology collaborations to enhance tissue analysis precision and biomarker identification.
About Persistence Market Research:
Business intelligence is the foundation of every business model employed by Persistence Market Research. Multi-dimensional sources are being put to work, which include big data, customer experience analytics, and real-time data collection. Thus, working on "micros" by Persistence Market Research helps companies overcome their "macro" business challenges.
Persistence Market Research is always way ahead of its time. In other words, it tables market solutions by stepping into the companies'/clients' shoes much before they themselves have a sneak pick into the market. The pro-active approach followed by experts at Persistence Market Research helps companies/clients lay their hands on techno-commercial insights beforehand, so that the subsequent course of action could be simplified on their part.
Contact Us:
Persistence Market Research
Teerth Technospace, Unit B-704
Survey Number - 103, Baner
Mumbai Bangalore Highway
Pune 411045, India
Email: sales@persistencemarketresearch.com
Web: https://www.persistencemarketresearch.com
This press release first seen on Brilad
COMTEX_447088448/2840/2024-01-31T01:59:31
